Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation

Clinical trial NCT00593645 · TERMINATED

Trial details

NCT number: NCT00593645
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myeloid Leukemia

Start date: 2007-11-01
Primary completion: 2008-12-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.